Corporate Responsibility at Merck

Corporate Responsibility at Merck

For more than a century, Merck has been inventing medicines and vaccines for the world’s most challenging diseases. And today we’re continuing to invent new approaches that save and improve lives so that people can positively contribute to a healthier and more hopeful world.

Our corporate responsibility approach is aligned with the company’s focus on invention, and underscores our commitment to overcoming the greatest obstacles to health and wellbeing, developing and rewarding our employees, protecting the environment, and operating with the highest standards of ethics and transparency.

We support public policies that advance the interests of patients, improve public health and promote access to medicines and innovation.

Visit to learn more about Corporate Responsibility at Merck.

Content from this campaign

Merck Named a FTSE4Good Constituent Member
FTSE Russell, a global index provider, has once again named Merck & Co., Inc. to the FTSE4Good Index, a compilation of publicly-traded companies that meet globally-recognized corporate responsibility standards. What exactly is a FTSE4Good designation? The FTSE4Good designation is based on the company’s adherence and dedication to strong environmental...
Aug 23, 2017 1:45 PM ET
Togo Becomes First Country in Africa to Validate the Elimination of Lymphatic Filariasis as a Public Health Problem
LOME, TOGO, April 18, 2017 /3BL Media/ -- GSK, Merck (known as MSD outside the United States and Canada), and the MECTIZAN® Donation Program (MDP) congratulate President Faure Gnassingbé, the government and the people of Togo for becoming the first country in Africa recognized by the World Health Organization to have eliminated lymphatic filariasis (LF) as a public health problem.   LF...
Apr 18, 2017 8:00 AM ET
Merck Foundation Grant Expands Project ECHO® in Vietnam and India
KENILWORTH, N.J., January 18, 2017 /3BL Media/ -- The Merck Foundation (Foundation) and the Extension for Community Healthcare Outcomes (ECHO) Institute™ at the University of New Mexico Health Sciences Center announced today that the Foundation has provided a grant of $7 million over five years to support the expansion of ...
Jan 18, 2017 9:00 AM ET
Merck Foundation Announces $10 Million Initiative to Improve Access to High-Quality Diabetes Care in Vulnerable and Underserved U.S. Communities
KENILWORTH, N.J., November 17, 2016 /3BL Media/ -- The Merck Foundation (Foundation) announced today the launch of a new initiative, Bridging the Gap: Reducing Disparities in Diabetes Care (Bridging the Gap), to improve access to high-quality diabetes care and reduce health disparities for vulnerable and underserved populations in the United States. With $10 million in funding from the...
Nov 17, 2016 9:00 AM ET
Merck Congratulates Guatemala as Fourth Country in Latin America to Achieve WHO Verification of Elimination of River Blindness
KENILWORTH, N.J., September 29, 2016 /3BL Media/ -- Merck (NYSE:MRK), known as MSD outside the United States and Canada, commends the government of Guatemala on being the fourth country in Latin America to receive World Health Organization (WHO) verification of the elimination of river blindness (onchocerciasis). This announcement comes one year after the international coalition,...
Sep 29, 2016 1:15 PM ET